Homepage
Author:
Skye Bioscience, Inc.
Posted Date:
May 13, 2026
UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
Skye Bioscience, Inc.
May 13, 2026
Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
Skye Bioscience, Inc.
May 12, 2026
Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit
Skye Bioscience, Inc.
April 30, 2026
Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development
Skye Bioscience, Inc.
April 30, 2026
Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Skye Bioscience, Inc.
March 11, 2026
1
2
Next
